Chardan Capital reaffirmed their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. TNYA has been the subject of several other reports. Canaccord Genuity Group decreased their price objective on Tenaya […]
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the stock […]
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has received a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued ratings on the stock in the […]
Casdin Capital LLC lifted its position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) by 5.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 6,381,377 shares of the company’s stock after purchasing an additional 302,517 shares during the quarter. Tenaya Therapeutics accounts for approximately […]
Research analysts at SVB Leerink started coverage on shares of Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) in a note issued to investors on Thursday, Marketbeat.com reports. The firm set an “outperform” rating and a $7.00 price target on the stock. SVB Leerink’s price objective suggests a potential upside of 255.33% from the stock’s current […]